Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GPR3 | P46089 | 1/20 | 0.36 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.36 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.36 |
| ▸ | ATM | Q13315 | 1/20 | 0.36 |
| ▸ | ALOX5 | P09917 | 1/20 | 0.34 |
| ▸ | TSPO | P30536 | 2/20 | 0.32 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.32 |
| ▸ | MAPT | P10636 | 2/20 | 0.32 |
| ▸ | HPGD | P15428 | 1/20 | 0.32 |
| ▸ | RAB9A | P51151 | 1/20 | 0.32 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.32 |
| ▸ | PIM3 | Q86V86 | 1/20 | 0.32 |
| ▸ | POLB | P06746 | 1/20 | 0.32 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.32 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.31 |
| ▸ | EDNRB | P24530 | 1/20 | 0.31 |
| ▸ | EDNRA | P25101 | 1/20 | 0.31 |
| ▸ | HDAC4 | P56524 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL18252524 | 0.96 | GPR3 (0.37) | GPR3L3MBTL1KDM4EATMALOX5 | |
| SCHEMBL18252540 | 0.96 | GPR3 (0.37) | GPR3L3MBTL1KDM4EATMALOX5 | |
| SCHEMBL18252543 | 0.91 | L3MBTL1 (0.45) | GPR3L3MBTL1KDM4EATMALOX5 | |
| SCHEMBL18252532 | 0.91 | L3MBTL1 (0.45) | GPR3L3MBTL1KDM4EATMALOX5 | |
| SCHEMBL18252589 | 0.91 | ATM (0.39) | GPR3L3MBTL1KDM4EATMALOX5 | |
| SCHEMBL14649206 | 0.91 | GPR3 (0.41) | GPR3L3MBTL1KDM4EATMALOX5 | |
| SCHEMBL14649266 | 0.91 | GPR3 (0.41) | GPR3L3MBTL1KDM4EATMALOX5 | |
| SCHEMBL14649107 | 0.91 | GPR3 (0.41) | GPR3L3MBTL1KDM4EATMALOX5 | |
| SCHEMBL11987380 | 0.91 | GPR3 (0.41) | GPR3L3MBTL1KDM4EATMALOX5 | |
| SCHEMBL17248418 | 0.91 | GPR3 (0.41) | GPR3L3MBTL1KDM4EATMALOX5 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10256411-B2 | Organic electroluminescent materials and devices | UNIVERSAL DISPLAY CORPORATION (US) | 2019-04-09 | — | — | US | disclosed |
| US-20170077409-A1 | ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES | UNIVERSAL DISPLAY CORPORATION (US) | 2017-03-16 | — | — | US | disclosed |
| US-20170077409-A1 | ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES | UNIVERSAL DISPLAY CORPORATION (US) | 2017-03-16 | — | — | US | disclosed |
| US-20160343951-A1 | ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES | UNIVERSAL DISPLAY CORPORATION (US) | 2016-11-24 | — | — | US | disclosed |
| US-20160343951-A1 | ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES | UNIVERSAL DISPLAY CORPORATION (US) | 2016-11-24 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20160343951-A1 | ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES | OSBP, OSBPL3, OSBPL8 | GPR3 1244/4885L3MBTL1 953/4885KDM4E 4543/4885 |
| US-20170077409-A1 | ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES | OSBP, OSBPL3, OSBPL8 | GPR3 1244/4885L3MBTL1 953/4885KDM4E 4543/4885 |
| US-10256411-B2 | Organic electroluminescent materials and devices | OSBP, OSBPL3, OSBPL8 | GPR3 1244/4885L3MBTL1 953/4885KDM4E 4543/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.